-
Industry | Biotechnology |
---|---|
Sector | Healthcare |
ISIN | None |
CurrencyCode | USD |
Exchange | NASDAQ |
Market Cap | 3M |
---|---|
Beta | 1.48 |
Dividend Yield | 0.0% |
Target Price | None |
PE Ratio | None |
Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for CMND using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024